Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06846216 · ClinicalTrials.gov registry record · NA

Combination of BTL-785F and HPM-6000UF Devices for Women's Intimate Wellness

A NA study, sponsored by BTL Industries.

Completed
Registry status
NA
Development phase
25
Enrollment target

NCT06846216 is a NA study that has completed, run by BTL Industries. The registered enrollment target is 25 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06846216, a NA study, has completed, sponsored by BTL Industries.

COMPLETED
Registry status
NA
Development phase
25 participants
Enrollment target

Study Summary

The goal of this clinical trial is to evaluate the combined application of BTL-785F and HPM-6000UF Devices in improving quality of life in women with negative changes in the urogenital system (vulvovaginal atrophy symptoms, urinary incontinence or sexual dysfunction). The main question it aims to answer is: Does the combined application of BTL-785F and HPM-6000UF Devices reduces the score of the Vulvovaginal Symptoms Questionnaire? Participants will: * Undergo 6 treatment sessions.Three sessions will consist of combined application of BTL-785F and HPM-6000UF devices and three sessions will consist of standalone application of the HPM-6000UF device. * Attend follow-up visits * Complete questionnaires

Interventions

  • DEVICE Treatment with BTL-785F and HPM-6000UF Devices

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2023-02-20
Est. Completion 2024-04-05
Phase NA

Sponsor

BTL Industries

40 total trials

What the Registry Record Tells You About NCT06846216

The ClinicalTrials.gov registry entry for NCT06846216 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is BTL Industries, which has 40 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Treatment with BTL-785F and HPM-6000UF Devices is the first listed.

NCT06846216 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT06846216 about?

NCT06846216 is a clinical study titled "Combination of BTL-785F and HPM-6000UF Devices for Women's Intimate Wellness". The goal of this clinical trial is to evaluate the combined application of BTL-785F and HPM-6000UF Devices in improving quality of life in women with negative changes in the urogenital system (vulvovaginal atrophy symptoms, urinary incontinence or sexual dysfunction). The main question it aims to an...

What is the current status of trial NCT06846216?

This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2023-02-20. Estimated completion is 2024-04-05.

What interventions are being tested in trial NCT06846216?

The interventions under investigation include: Treatment with BTL-785F and HPM-6000UF Devices (DEVICE).

Who is sponsoring clinical trial NCT06846216?

This trial is sponsored by BTL Industries, which has 40 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.